These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 17308358

  • 1. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma.
    Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV.
    Endocr Pathol; 2006; 17(3):213-23. PubMed ID: 17308358
    [Abstract] [Full Text] [Related]

  • 2. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I, Isic T, Havelka M, Tatic S, Cvejic D, Savin S.
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR, Gucer H.
    Pol J Pathol; 2017 May; 68(1):1-10. PubMed ID: 28547974
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL.
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [Abstract] [Full Text] [Related]

  • 5. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS, Teng XD, Ding W, Zhou J, Yao HT, Ying LX, Xu LM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [Abstract] [Full Text] [Related]

  • 6. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility.
    Skaria PE, Ahmed AA, Yin H, Nicol K, Reid KJ, Singh V.
    Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of thyroid follicular neoplasms and BRAF mutation correlation.
    Atik E, Guray M, Gunesacar R, Ozgur T, Canda T.
    Indian J Cancer; 2014 May; 51(1):63-8. PubMed ID: 24947099
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S, Michalak S, Valo I, Saint-André JP.
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
    Park YJ, Kwak SH, Kim DC, Kim H, Choe G, Park DJ, Jang HC, Park SH, Cho BY, Park SY.
    J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
    [Abstract] [Full Text] [Related]

  • 10. HBME-1 and CD15 immunocytochemistry in the follicular variant of thyroid papillary carcinoma.
    Ohta M, Ookoshi T, Naiki H, Imamura Y.
    Pathol Int; 2015 Mar; 65(3):119-25. PubMed ID: 25597783
    [Abstract] [Full Text] [Related]

  • 11. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB, Şenol S, Şimşek BÇ, Sağıroğlu J, Aydın A.
    Int J Clin Exp Pathol; 2015 Mar; 8(4):3670-80. PubMed ID: 26097548
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma.
    Cho H, Kim JY, Oh YL.
    Pathol Int; 2018 Nov; 68(11):605-613. PubMed ID: 30350394
    [Abstract] [Full Text] [Related]

  • 13. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN, He L, Cheng JQ, Chen SC, Zhao HF, Zhai JP, Zhang J.
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
    [Abstract] [Full Text] [Related]

  • 14. Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior.
    Isic Dencic T, Cvejic D, Paunovic I, Tatic S, Havelka M, Savin S.
    Med Oncol; 2013 Mar; 30(1):362. PubMed ID: 23269585
    [Abstract] [Full Text] [Related]

  • 15. [The use of immunohistochemistry in the differential diagnosis of thyroid gland tumors with follicular growth pattern].
    Laco J, Ryska A.
    Cesk Patol; 2006 Jul; 42(3):120-4. PubMed ID: 16955558
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 17. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 18. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A, Etit D, Bayol U, Altinel D, Tan S.
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [Abstract] [Full Text] [Related]

  • 19. Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma.
    Cameron BR, Berean KW.
    J Otolaryngol; 2003 Oct; 32(5):319-22. PubMed ID: 14974863
    [Abstract] [Full Text] [Related]

  • 20. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D, Lipkovski JM, Boričic I, Soldatović I, Božic V, Cvejić D, Tatić S.
    Diagn Pathol; 2015 Oct 26; 10():196. PubMed ID: 26503236
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.